CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Balance, Beginning at Dec. 31, 2024	$ 9	$ 837,363	$ 420	$ (378,576)	$ 459,216
Balance, Beginning (in shares) at Dec. 31, 2024	94,838,466
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		2,261			2,261
Exercise of stock options (shares)	367,217
Stock-based compensation		9,059			9,059
Other comprehensive loss			(19)		(19)
Net loss				(40,798)	(40,798)
Balance, Ending at Mar. 31, 2025	$ 9	848,683	401	(419,374)	429,719
Balance, Ending (in shares) at Mar. 31, 2025	95,205,683
Balance, Beginning at Dec. 31, 2025	$ 10	1,067,941	677	(546,371)	$ 522,257
Balance, Beginning (in shares) at Dec. 31, 2025	106,249,579				106,249,579
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		12,173			$ 12,173
Exercise of stock options (shares)	1,231,943
Stock-based compensation		8,715			8,715
Other comprehensive loss			(929)		(929)
Net loss				(49,013)	(49,013)
Balance, Ending at Mar. 31, 2026	$ 10	$ 1,088,829	$ (252)	$ (595,384)	$ 493,203
Balance, Ending (in shares) at Mar. 31, 2026	107,481,522				107,481,522